Recent Advances in the Probe Development of Technetium-99m Molecular Imaging Agents

Author(s): Paul D. Benny, Adam L. Moore

Journal Name: Current Organic Synthesis

Volume 8 , Issue 4 , 2011

Become EABM
Become Reviewer


The development of technetium based diagnostic imaging agents continues to remain a high impact area in nuclear medicine research. In particular, the single photon emitting radionuclide 99mTc comprises the majority of diagnostic imaging scans performed daily at hospitals and clinics. While research with 99mTc has been active for several decades, this review focuses on the overview of recent developments and current trends surrounding 99mTc applications. Discussion includes the fundamental design of 99mTc complexes, new labeling methodologies, and development of molecular probes for the next generation of in vivo diagnostic imaging agents.

Keywords: Technetium, complexes, radiopharmaceuticals, nuclear medicine, SPECT, Probe, Molecular Imaging, TC CHEMISTRY, PEPTIDE BASED Tc AGENTS, NANOPARTICLES

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2011
Page: [566 - 583]
Pages: 18
DOI: 10.2174/157017911796117214
Price: $65

Article Metrics

PDF: 10